WHO calls for $20m for research on DU

Epidemiology is the weak leak in understanding depleted uranium, says the World Health Organisation, while offering to plug the gap.

Written byRobert Walgate
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

LONDON Following a visit by four experts to the Balkans last week, the World Health Organization has estimated that $20 million is needed for epidemiological research on DU during the next four years.

If the money were forthcoming, WHO says it would undertake "in-depth epidemiological and toxicological studies" into the possible health effects of depleted uranium (DU) — and other possible toxic materials used in warfare — in the Balkans and the Gulf.

Although experts' current thinking is that the risk from exposure to DU is low, information is insufficient for firm conclusions, WHO says. "Evidence on the incidence of cancers needs to be strengthened… to draw any epidemiological conclusions," says Xavier Leus, Director for the Emergency and Humanitarian Action Department of WHO. "There is also very little information on other possible risk factors for civilians and the military that may be equally important. We need to examine possible connections ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies